185 related articles for article (PubMed ID: 35468938)
1. Genomic and TCR profiling data reveal the distinct molecular traits in epithelial ovarian cancer histotypes.
Zhu S; Zhang C; Cao D; Bai J; Yu S; Chen J; Wang J; Ren T; Yang J; Yu M; Xiao X; Gong Y; Guan Y; Li P; Yue Y; Yin R; Wang Y; An R; Lou G; Yuan J; Zhang G; Xia X; Yang L; Xiang Y
Oncogene; 2022 May; 41(22):3093-3103. PubMed ID: 35468938
[TBL] [Abstract][Full Text] [Related]
2. Clinical and pathological associations of PTEN expression in ovarian cancer: a multicentre study from the Ovarian Tumour Tissue Analysis Consortium.
Martins FC; Couturier DL; Paterson A; Karnezis AN; Chow C; Nazeran TM; Odunsi A; Gentry-Maharaj A; Vrvilo A; Hein A; Talhouk A; Osorio A; Hartkopf AD; Brooks-Wilson A; DeFazio A; Fischer A; Hartmann A; Hernandez BY; McCauley BM; Karpinskyj C; de Sousa CB; Høgdall C; Tiezzi DG; Herpel E; Taran FA; Modugno F; Keeney G; Nelson G; Steed H; Song H; Luk H; Benitez J; Alsop J; Koziak JM; Lester J; Rothstein JH; de Andrade JM; Lundvall L; Paz-Ares L; Robles-Díaz L; Wilkens LR; Garcia MJ; Intermaggio MP; Alcaraz ML; Brett MA; Beckmann MW; Jimenez-Linan M; Anglesio M; Carney ME; Schneider M; Traficante N; Pejovic N; Singh N; Le N; Sinn P; Ghatage P; Erber R; Edwards R; Vierkant R; Ness RB; Leung S; Orsulic S; Brucker SY; Kaufmann SH; Fereday S; Gayther S; Winham SJ; Kommoss S; Pejovic T; Longacre TA; McGuire V; Rhenius V; Sieh W; Shvetsov YB; Whittemore AS; Staebler A; Karlan BY; Rodriguez-Antona C; Bowtell DD; Goode EL; Høgdall E; Candido Dos Reis FJ; Gronwald J; Chang-Claude J; Moysich KB; Kelemen LE; Cook LS; Goodman MT; Fasching PA; Crawford R; Deen S; Menon U; Huntsman DG; Köbel M; Ramus SJ; Pharoah PDP; Brenton JD
Br J Cancer; 2020 Sep; 123(5):793-802. PubMed ID: 32555365
[TBL] [Abstract][Full Text] [Related]
3. Distinct transcriptional programs stratify ovarian cancer cell lines into the five major histological subtypes.
Barnes BM; Nelson L; Tighe A; Burghel GJ; Lin IH; Desai S; McGrail JC; Morgan RD; Taylor SS
Genome Med; 2021 Sep; 13(1):140. PubMed ID: 34470661
[TBL] [Abstract][Full Text] [Related]
4. Investigating the suitability of
McCabe A; Zaheed O; McDade SS; Dean K
Front Cell Dev Biol; 2023; 11():1104514. PubMed ID: 36861035
[TBL] [Abstract][Full Text] [Related]
5. Cell State of Origin Impacts Development of Distinct Endometriosis-Related Ovarian Carcinoma Histotypes.
Beddows I; Fan H; Heinze K; Johnson BK; Leonova A; Senz J; Djirackor S; Cho KR; Pearce CL; Huntsman DG; Anglesio MS; Shen H
Cancer Res; 2024 Jan; 84(1):26-38. PubMed ID: 37874327
[TBL] [Abstract][Full Text] [Related]
6. Transcriptional Characterization of Stage I Epithelial Ovarian Cancer: A Multicentric Study.
Calura E; Ciciani M; Sambugaro A; Paracchini L; Benvenuto G; Milite S; Martini P; Beltrame L; Zane F; Fruscio R; Marchette MD; Borella F; Tognon G; Ravaggi A; Katsaros D; Bignotti E; Odicino F; D'Incalci M; Marchini S; Romualdi C
Cells; 2019 Dec; 8(12):. PubMed ID: 31805750
[TBL] [Abstract][Full Text] [Related]
7. Morphological and molecular heterogeneity of epithelial ovarian cancer: Therapeutic implications.
Romero I; Leskelä S; Mies BP; Velasco AP; Palacios J
EJC Suppl; 2020 Aug; 15():1-15. PubMed ID: 33240438
[TBL] [Abstract][Full Text] [Related]
8. Morphologic Reproducibility, Genotyping, and Immunohistochemical Profiling Do Not Support a Category of Seromucinous Carcinoma of the Ovary.
Rambau PF; McIntyre JB; Taylor J; Lee S; Ogilvie T; Sienko A; Morris D; Duggan MA; McCluggage WG; Köbel M
Am J Surg Pathol; 2017 May; 41(5):685-695. PubMed ID: 28125452
[TBL] [Abstract][Full Text] [Related]
9. Histotype-specific copy-number alterations in ovarian cancer.
Huang RY; Chen GB; Matsumura N; Lai HC; Mori S; Li J; Wong MK; Konishi I; Thiery JP; Goh L
BMC Med Genomics; 2012 Oct; 5():47. PubMed ID: 23078675
[TBL] [Abstract][Full Text] [Related]
10. Evolving population-based statistics for rare epithelial ovarian cancers.
Matsuo K; Machida H; Matsuzaki S; Grubbs BH; Klar M; Roman LD; Sood AK; Gershenson DM; Wright JD
Gynecol Oncol; 2020 Apr; 157(1):3-11. PubMed ID: 31954534
[TBL] [Abstract][Full Text] [Related]
11. Molecular characteristics and clinical behaviour of epithelial ovarian cancers.
Hollis RL
Cancer Lett; 2023 Feb; 555():216057. PubMed ID: 36627048
[TBL] [Abstract][Full Text] [Related]
12. [Expression and significance of PD-1 and PD-L1 in the specimens of epithelial ovarian cancer].
Ju C; Gao JC; Zhang PX; Zhang KN; Yang S; Kang TJ; Zhao HZ; Qi WJ; Zhang QP; Kong FD; Guan HW; Shi H
Zhonghua Fu Chan Ke Za Zhi; 2020 Aug; 55(8):529-534. PubMed ID: 32854477
[No Abstract] [Full Text] [Related]
13. Morphologic and Molecular Characteristics of Mixed Epithelial Ovarian Cancers.
Mackenzie R; Talhouk A; Eshragh S; Lau S; Cheung D; Chow C; Le N; Cook LS; Wilkinson N; McDermott J; Singh N; Kommoss F; Pfisterer J; Huntsman DG; Köbel M; Kommoss S; Gilks CB; Anglesio MS
Am J Surg Pathol; 2015 Nov; 39(11):1548-57. PubMed ID: 26099008
[TBL] [Abstract][Full Text] [Related]
14. Overview of Tumor Heterogeneity in High-Grade Serous Ovarian Cancers.
Azzalini E; Stanta G; Canzonieri V; Bonin S
Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37894756
[TBL] [Abstract][Full Text] [Related]
15. MiRNA landscape in stage I epithelial ovarian cancer defines the histotype specificities.
Calura E; Fruscio R; Paracchini L; Bignotti E; Ravaggi A; Martini P; Sales G; Beltrame L; Clivio L; Ceppi L; Di Marino M; Fuso Nerini I; Zanotti L; Cavalieri D; Cattoretti G; Perego P; Milani R; Katsaros D; Tognon G; Sartori E; Pecorelli S; Mangioni C; D'Incalci M; Romualdi C; Marchini S
Clin Cancer Res; 2013 Aug; 19(15):4114-23. PubMed ID: 23766361
[TBL] [Abstract][Full Text] [Related]
16. T-Cell Receptor Repertoire Characteristics Associated with Prognostic Significance in High-Grade Serous Ovarian Carcinoma.
Kim JW; Kim S; Yang SY; Joung JG; Hwang S
Genes (Basel); 2023 Mar; 14(4):. PubMed ID: 37107543
[TBL] [Abstract][Full Text] [Related]
17. Genomic consequences of aberrant DNA repair mechanisms stratify ovarian cancer histotypes.
Wang YK; Bashashati A; Anglesio MS; Cochrane DR; Grewal DS; Ha G; McPherson A; Horlings HM; Senz J; Prentice LM; Karnezis AN; Lai D; Aniba MR; Zhang AW; Shumansky K; Siu C; Wan A; McConechy MK; Li-Chang H; Tone A; Provencher D; de Ladurantaye M; Fleury H; Okamoto A; Yanagida S; Yanaihara N; Saito M; Mungall AJ; Moore R; Marra MA; Gilks CB; Mes-Masson AM; McAlpine JN; Aparicio S; Huntsman DG; Shah SP
Nat Genet; 2017 Jun; 49(6):856-865. PubMed ID: 28436987
[TBL] [Abstract][Full Text] [Related]
18. A multi-level investigation of the genetic relationship between endometriosis and ovarian cancer histotypes.
Mortlock S; Corona RI; Kho PF; Pharoah P; Seo JH; Freedman ML; Gayther SA; Siedhoff MT; Rogers PAW; Leuchter R; Walsh CS; Cass I; Karlan BY; Rimel BJ; ; Montgomery GW; Lawrenson K; Kar SP
Cell Rep Med; 2022 Mar; 3(3):100542. PubMed ID: 35492879
[TBL] [Abstract][Full Text] [Related]
19. The proteome of clear cell ovarian carcinoma.
Ji JX; Cochrane DR; Negri GL; Colborne S; Spencer Miko SE; Hoang LN; Farnell D; Tessier-Cloutier B; Huvila J; Thompson E; Leung S; Chiu D; Chow C; Ta M; Köbel M; Feil L; Anglesio M; Goode EL; Bolton K; Morin GB; Huntsman DG
J Pathol; 2022 Dec; 258(4):325-338. PubMed ID: 36031730
[TBL] [Abstract][Full Text] [Related]
20. Integrative genomics approach identifies molecular features associated with early-stage ovarian carcinoma histotypes.
Engqvist H; Parris TZ; Biermann J; Rönnerman EW; Larsson P; Sundfeldt K; Kovács A; Karlsson P; Helou K
Sci Rep; 2020 May; 10(1):7946. PubMed ID: 32409713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
